Skip to main content

Advertisement

Log in

Taste Mask, Design and Evaluation of an Oral Formulation Using Ion Exchange Resin as Drug Carrier

  • Research Article
  • Published:
AAPS PharmSciTech Aims and scope Submit manuscript

Abstract

The purpose of this research was to mask the bitter taste of Diphenhydramine Hydrochloride (DPH) using cation exchange resins. Indion 234 and Tulsion 343 that contained crosslinked polyacrylic backbone were used. The drug resin complexes (DRC) were prepared by batch process by taking drug: resin ratios 1:1, 1:2, and 1:3. The optimum drug: resin ratio and the time required for maximum complexation was determined. The drug resinates were evaluated for the drug content, taste, micromeritic properties drug release and X-ray diffraction (PXRD). Effervescent and dispersible tablets were developed from optimum drug: resin ratios of 1:2 and 1:1. The formulations were evaluated for uniformity of dispersion, disintegration time, and in vitro dissolution. The X-ray diffraction study confirmed the monomolecularity of entrapped drug in the resin beads. The taste evaluation depicted the successful taste masking of DPH with drug resin complexes. The drug release of 95% in 15 min was observed for effervescent and dispersible tablets.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. H. Sohi, Y. Sultana, and R. K. Khar. Taste masking technologies in oral pharmaceuticals: recent developments and approaches. Drug Dev. Ind. Pharm. 30:429–448 (2004).

    Article  PubMed  CAS  Google Scholar 

  2. T. Yakoo, and H. Hirohata. Composition for oral cavity. JP05, 000,931, January 8, 1993.

  3. R. C. Fiusz. Taste masking of pharmaceutical floss with phenol, US Patent5, 028,632, July 02, 1992.

  4. F. Wehling, and S. Schedule. Effervescent dosage form with microparticles. US Patent5, 178,878, January 12, 1993.

  5. G. A. Depalomo. Composition based on ibuprofen, for oral dosage usage. Eur. Patent Appl. EP0560207, September 15, 1993.

  6. W. G. Gowan, and R. D. Bruce. Aliphatic ester as a solventless coating pharmaceuticals. Can. Pat. Appl. CA2082137, November 4, 1993.

  7. J. Block, A. Cassiere, and M. O. Christens. Galenicals Form. Ger. Offen DE3900811, July19, 1990.

  8. R. W. Shen. Taste masking of ibuprofen by fluid bed coating. US Patent5, 55,152, September 3, 1996.

  9. M. J. Poelinger, N. Rupp, and R, Buecheler M. D. Taste masked pharmaceuticals composition. Eur. Pat. Appl. EP0551820, July 21, 1993.

  10. M. L. Lorenzo-Lamosa, M. Kuna, and J. Vila Jato. Development of microencapsulated form of Cefuroxime axetil using pH sensitive acrylic polymers. J. Microencapsule. 14:660–616 (1997).

    Google Scholar 

  11. Y. Ikezuki. Raw material for food and medicine and its production. JP02, 291,244, December 3, 1990.

  12. S. P. Manek, and V. S. Kamat. Evaluation of Indion CRP-244 and CRP-254 as sustained release and taste masking agents. Indian J. Pharm. Sci. 43:209–212 (1981).

    CAS  Google Scholar 

  13. S. Niazi, and A. Shemesh. Chewing gum containing a medicament and taste masker. US Patent04, 639,368, January 27, 1987.

  14. C. M. Blasé, and M. N. Shah. Taste masked pharmaceutical suspensions for pharmaceutical actives. Eur. Pat. Appl. EP0556057, August 18, 1993.

  15. N. C. Diamini, and J. H. Tsau. Taste masked compositions. Eur. Pat. Appl. EP0212641, March 4, 1987.

  16. Drugs and pharmaceuticals sciences. In M. J. Rathbone, J. Hadgraft, and M. S. Roberts (eds.), Drug Delivery Technology, Marcel Dekker, Inc., New York, 2003, pp. 191–202.

  17. S. Borodkin, and D. P. Sundberg. Polycarboxylic acid ion-exchange resin adsorbates for taste coverage in chewable tablets. J. Pharm. Sci. 60:1523–1527 (1971).

    Article  PubMed  CAS  Google Scholar 

  18. M. Sriwongjanya, and R. Bodmeier. Entrapment of drug loaded ion-exchange particles within polymer microparticles. Int. J. Pharm. 158:29–38 (1997).

    Article  CAS  Google Scholar 

  19. M. Cuna, J. L. V. Jato, and D. Torres. Controlled- release liquid suspensions based on ion- exchange particles within acrylic microcapsules. Int. J. Pharm. 199:151–158 (2000).

    Article  PubMed  CAS  Google Scholar 

  20. H. Ichikawa, K. Fujioka, M. C. Adeyeye, and Y. Fukamori. Use of ion-exchange resins to prepare 100µm- seized microcapsules with prolonged drug-release by the Wurster process. Int. J. Pharm. 216:67–76 (2001).

    Article  PubMed  CAS  Google Scholar 

  21. S. Borodkin. Ion exchange resins and sustained release. In J. Swarbrick, and J. C. Boylan (eds.), Encyclopedia of pharmaceutical technology. Vol 8., Marcel Dekker, Inc., New York, 1993, pp. 203–216.

    Google Scholar 

  22. R. E. Notari. Biopharmaceutics and clinical pharmaceutics, 4th ed., Marcel Dekker, Inc., New York and Basel, 1987, pp. 130–218.

    Google Scholar 

  23. Y. Raghunathan, L. Amsel, and O. Hinsvark. Sustained-released drug delivery system I: coated ion-exchange resins system for phenylpropanolamine and other drugs. J. Pharm. Sci. 70:379–384 (1981).

    Article  PubMed  CAS  Google Scholar 

  24. K. E. Ogger, C. Noory, J. Gabay, V. P. Shah, and J. P. Skelly. Dissolution profiles of resins-based oral suspensions. Pharm. Technol. 9:84–91 (1991).

    Google Scholar 

  25. G. M. Burke, R. W. Mendes, and S. S. Jambhekar. Investigation of the application of ion exchange resins as a sustained release drug delivery system for propranolol hydrochloride. Drug Dev. Ind. Pharm. 12:713–732 (1986).

    Article  CAS  Google Scholar 

  26. W. J. Irwin, K. A. Belaid, and H. O. Alpar. Drug-delivery by ion-exchange. Part III: interaction of ester pro-drugs of propranolol with cationic exchange resins. Drug Dev. Ind. Pharm. 13:2047–2066 (1987).

    Article  CAS  Google Scholar 

  27. M. Sriwongjanya, and R. Bodmeier. Effect of ion exchange resins on the drug release form matrix tablets. Eur. J. Pharm. Biopharm. 46:321–327 (1998).

    Article  PubMed  CAS  Google Scholar 

  28. British Pharmacopeia, Vol. II. Great Britain Published by The Stationary Office under license from the Controller of Her Majesty Stationary Office for the Department of Health on behalf of the Health Ministers, 2001:594–595.

  29. The United Stated Pharmacopeia XX III/ National Formulary XVIII. U.S. Pharmacopoeial convention, Rockville, MD, 1980:532–533.

  30. Ion exchange resins used in pharmaceutical industry. Available at: www.indion.com Accessed on June 30, 2006.

  31. Ion exchange resins used in pharmaceutical industry. Available at: www.thermaxindia.com Accessed on June 30, 2006.

  32. P. Akkaramongakolporn, K. Terada, and E. Yonemochi. Molecular properties of propranolol hydrochloride prepared as drug-resin complexes. Drug Dev. Ind. Pharm. 27:359–364 (2001).

    Article  Google Scholar 

  33. S. Pisal, R. Zainuddin, P. Nalawade, K. Mahadik, and S. Kadam. Drug release of polyethylene-glycol-treated ciprofloxacin-Indion 234 complexes. AAPS PharmSciTech. 5:4 (2002)Article 62.

    Google Scholar 

  34. L. Lachman, H. A. Lieberman, and J. Kanig. The Theory and Practice of Industrial Pharmacy, 3rd edition, Varghese publishing house, Bombay, 1987.

    Google Scholar 

Download references

Acknowledgement

The authors are thankful to Supriya Chemical Limited (Mumbai, India), Ion Exchange Limited (Mumbai, India), Thermax Limited (Pune, India) and Libra chemicals (Mumbai, India) for supplying gift sample of Diphenhydramine Hydrochloride, Indion resins, Tulsion resins, micro crystalline cellulose (Avicel PH 101) and polyvinlypyrolidone K-30. The authors also acknowledge to Faculty of Physics, Pune University (Pune, India) for the facility of PXRD.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Kiran Bhise.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bhise, K., Shaikh, S. & Bora, D. Taste Mask, Design and Evaluation of an Oral Formulation Using Ion Exchange Resin as Drug Carrier. AAPS PharmSciTech 9, 557–562 (2008). https://doi.org/10.1208/s12249-008-9056-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1208/s12249-008-9056-6

Key words

Navigation